A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases | MicrobiomeTrials← Back to trialsNCT07123519
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-08-13Est. Completion: 2027-08-13
Enrollment target: 18 participants Locations- Institute of Hematology & Blood Diseases Hospital, China, Tianjin, China
Other microbiome trials you might be interested in
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
Background:
Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. Peop…
Bethesda, United StatesEst. completion May 31, 2027
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is an autoimmune rheumatic disease. Patients report that fatigue has a significant im…
Edinburgh, United KingdomEst. completion Mar 9, 2026